Young plasma-derived exosomes deliver YOD1 to induce M2 polarization and ameliorate osteoporosis via mTOR signaling pathways.
8 affiliations
- 1Nankai University School of Medicine, Tianjin, China.
- 2Department of Orthopedic Research Center, the Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.
- 3Engineering Research Center of Orthopedic Minimally Invasive Intelligent Equipment, China Ministry of Education.
- 4Key Laboratory of Biomechanics of Hebei Province, Shijiazhuang, Hebei, China.
- 5NHC Key Laboratory of Intelligent Orthopaedic Equipment, Shijiazhuang, Hebei, China.
- 6Key Laboratory of Precise Assessment, Diagnosis, and Treatment of Soft Tissue Injury of Hebei Province.
- 7Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- 8Department of Orthopedic Oncology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China.
Abstract
This study aimed to evaluate the therapeutic potential of young plasma-derived exosomes (Y-Exos) in osteoporosis, focusing on their capacity to modulate macrophage polarization and bone homeostasis. Ovariectomized (OVX) mice were administered young plasma, aged plasma, exosome-depleted plasma, or plasma-derived exosomes. Bone mass, macrophage polarization, and osteoblast/osteoclast activity were analyzed by micro-CT, flow cytometry, and histology. Human Y-Exos were isolated to examine their direct effects on BMSC osteogenesis and BMM polarization, as well as indirect effects on osteoclastogenesis. Proteomic and transcriptomic approaches were employed to identify key functional proteins and underlying mechanisms. For results, young plasma significantly improved bone mass, increased CD206⁺M2 macrophages, and upregulated osteogenic and anti-inflammatory genes in OVX mice-effects that were largely abolished upon exosome depletion. Y-Exos were internalized by target cells, promoted BMSC osteogenesis, reduced M1 markers (CD86, iNOS) in LPS-stimulated BMMs, and enhanced M2 markers (CD206, ARG1), and, indirectly, reversed osteoclast activation and rescued osteogenic suppression. In vivo, Y-Exos increased bone mass, elevated OCN and CD206 expression, and expanded the Lin⁻Sca-1⁺c-Kit⁺ (LSK) cell population. YOD1 was identified as a key effector in Y-Exos and was downregulated with aging. Mechanistically, Y-Exos delivered YOD1 to activate mTOR in BMMs, driving M2 polarization, and to BMSCs, promoting osteogenesis via Hippo signaling. In conclusion, Y-Exos deliver YOD1 to induce M2 macrophage polarization through mTOR activation and enhance osteogenesis via Hippo signaling, thereby improving the bone immune microenvironment and effectively ameliorating osteoporosis. These findings reveal a new immunomodulatory mechanism and provide an experimental basis for Y-Exos-based therapy in osteoporosis.
Related
- Engineering exosomes-mediated RNA delivery regulates bone homeostasis and alleviates osteoporosis.
- Bone-targeting engineered exosomes delivering teriparatide mRNA for the treatment of osteoporosis.
- A nanosystem manipulates angiocrine signaling for cardioprotection in male mice by relocalizing endothelial exosomes
- Exosomes from DGKK-Knockdown CD4+T Cells Alleviate Sepsis by Inhibiting the DAG/PKC/ROS Pathway-Mediated M1 Macrophage Polarization and Reducing Endothelial Permeability
- Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling
BibTeX
@article{wang2026young,
title = {{Young plasma-derived exosomes deliver YOD1 to induce M2 polarization and ameliorate osteoporosis via mTOR signaling pathways.}},
author = {Jiahao Wang and Xiaokang Zhang and Siteng Li and Qi Zhang and Jiheng Xiao and Chengbin Huang and Jianpeng Chen and Yang Luo and Zeming Shan and Ziping Chen and Ling Wang and Yingze Zhang},
journal = {International journal of biological sciences},
year = {2026},
month = sep,
doi = {10.7150/ijbs.138620},
url = {https://europepmc.org/article/MED/42910259},
note = {CC BY},
}
RIS
TY - JOUR
TI - Young plasma-derived exosomes deliver YOD1 to induce M2 polarization and ameliorate osteoporosis via mTOR signaling pathways.
AU - Jiahao Wang
AU - Xiaokang Zhang
AU - Siteng Li
AU - Qi Zhang
AU - Jiheng Xiao
AU - Chengbin Huang
AU - Jianpeng Chen
AU - Yang Luo
AU - Zeming Shan
AU - Ziping Chen
AU - Ling Wang
AU - Yingze Zhang
PY - 2026
DA - 2026/09/18
JO - International journal of biological sciences
DO - 10.7150/ijbs.138620
UR - https://europepmc.org/article/MED/42910259
AB - This study aimed to evaluate the therapeutic potential of young plasma-derived exosomes (Y-Exos) in osteoporosis, focusing on their capacity to modulate macrophage polarization and bone homeostasis. Ovariectomized (OVX) mice were administered young plasma, aged plasma, exosome-depleted plasma, or plasma-derived exosomes. Bone mass, macrophage polarization, and osteoblast/osteoclast activity were analyzed by micro-CT, flow cytometry, and histology. Human Y-Exos were isolated to examine their direct effects on BMSC osteogenesis and BMM polarization, as well as indirect effects on osteoclastogenesis. Proteomic and transcriptomic approaches were employed to identify key functional proteins and underlying mechanisms. For results, young plasma significantly improved bone mass, increased CD206⁺M2 macrophages, and upregulated osteogenic and anti-inflammatory genes in OVX mice-effects that were largely abolished upon exosome depletion. Y-Exos were internalized by target cells, promoted BMSC osteogenesis, reduced M1 markers (CD86, iNOS) in LPS-stimulated BMMs, and enhanced M2 markers (CD206, ARG1), and, indirectly, reversed osteoclast activation and rescued osteogenic suppression. In vivo, Y-Exos increased bone mass, elevated OCN and CD206 expression, and expanded the Lin⁻Sca-1⁺c-Kit⁺ (LSK) cell population. YOD1 was identified as a key effector in Y-Exos and was downregulated with aging. Mechanistically, Y-Exos delivered YOD1 to activate mTOR in BMMs, driving M2 polarization, and to BMSCs, promoting osteogenesis via Hippo signaling. In conclusion, Y-Exos deliver YOD1 to induce M2 macrophage polarization through mTOR activation and enhance osteogenesis via Hippo signaling, thereby improving the bone immune microenvironment and effectively ameliorating osteoporosis. These findings reveal a new immunomodulatory mechanism and provide an experimental basis for Y-Exos-based therapy in osteoporosis.
SN - 1449-2288
ER -